|
|
| evunzekibart (ATOR-1017) / Alligator Biosci (0 Trials) |
|
| Evusheld (cilgavimab/tixagevimab) / AstraZeneca (0 Trials) |
|
| EVX-01 / Evaxion (0 Trials) |
|
| EVX-02 / Evaxion (0 Trials) |
|
| EVX-020 / Evexta Bio (0 Trials) |
|
| EVX-03 / Evaxion (0 Trials) |
|
| EVX-B1 / Evaxion (0 Trials) |
|
| EVX-B2 / Evaxion (0 Trials) |
|
| EVX-B3 / Evaxion (0 Trials) |
|
| Evzio (naloxone auto-injector) / Kaleo (1 Trials) |
|
| ex vivo expanded allogeneic γδ T Cells / Emory University (0 Trials) |
|
| ex vivo expanded gamma delta T-lymphocyte therapy / Wuhan University, Jinan University, GD Kongming Biotech (0 Trials) |
|
| Ex vivo expanded unmodified Vd2+ gamma/delta-T cells / PhosphoGam (0 Trials) |
|
| ex vivo lentiviral gene therapy / Fortress (0 Trials) |
|
| EX-301 / Exinda Therap (0 Trials) |
|
| Ex-Rad (recilisib) / Onconova (0 Trials) |
|
| ex-vivo expanded allogeneic γδT cells / Beijing GD (0 Trials) |
|
| EX1000 / Novo Nordisk (0 Trials) |
|
| EX937 / Exxel Pharma (0 Trials) |
|
| Exacin (isepamicin sulfate) / China Medical System (0 Trials) |
|
| exaluren (ELX-02) / Eloxx Pharma (1 Trials) |
|
| exaluren inhaled (ELX-02 inhaled) / Eloxx Pharma (0 Trials) |
|
| exarafenib (KIN-2787) / Pierre Fabre (0 Trials) |
|
| Exblifep (cefepime/enmetazobactam) / Allecra (0 Trials) |
|
| EXC 001 / Pfizer (0 Trials) |
|
| Excellair / ZaBeCor (0 Trials) |
|
| Excindogen / Vitalgenics (0 Trials) |
|
| exebacase (CF-301) / ContraFect (1 Trials) |
|
| EXEL 6309 / Exelixis (0 Trials) |
|
| EXEL 8232 / Exelixis (0 Trials) |
|
| EXEL-2255 / Exelixis, BMS (0 Trials) |
|
| Exelbine (vinorelbine) / Savara (0 Trials) |
|
| exemestane / Generic mfg. (123 Trials) |
|
| Exemptia (adalimumab biosimilar) / Zydus Lifesci (0 Trials) |
|
| exenatide biosimilar / Paras Biopharma (0 Trials) |
|
| exenatide DUROS subcutaneous delivery system (ITCA 650) / i20 Therap (0 Trials) |
|
| exenatide extended release (FT 228) / Avadel (0 Trials) |
|
| exenatide implant (ITCA 650/12M) / i20 Therap (0 Trials) |
|
| exenatide implant (NPM-119) / Vivani Medical (0 Trials) |
|
| exenatide once monthly suspension / BMS (0 Trials) |
|
| exenatide SR (DA-3091) / Dong-A (0 Trials) |
|
| exenatide SR once-monthly (PT304) / Peptron (0 Trials) |
|
| exenatide SR two week formulation (PT302) / Peptron (0 Trials) |
|
| exenatide SR two-week formulation (PT320) / Peptron (1 Trials) |
|
| exenatide transdermal patch / BMS, Nitto Denko (0 Trials) |
|
| exenatide-XTEN (VRS-859) / Aravive (0 Trials) |
|
| exenatide-XTEN + glucagon-XTEN (VRS-859 + AMX-808) / Aravive, Sanofi (0 Trials) |
|
| exeporfinium chloride (XF-73) / Destiny Pharma (0 Trials) |
|
| Exetin-A (epoetin alfa biosimilar) / PiSA Farmaceutica (0 Trials) |
|
| Exfoliac / Zenotech (0 Trials) |
|
| EXG-5003 / Elixirgen Therap (0 Trials) |
|
| EXG001-307 / Exegenesis Bio (0 Trials) |
|
| EXG34217 / Elixirgen Therap (0 Trials) |
|
| Exherin (ADH-1) / Fennec Pharma (0 Trials) |
|
| exicorilant (CORT125281) / Corcept Therap (2 Trials) |
|
| Exkivity (mobocertinib) / Takeda (6 Trials) |
|
| exlinkibart (LVGN6051) / Lyvgen (0 Trials) |
|
| EXN407 / Exonate, J&J (0 Trials) |
|
| Exo1 / Exotect, National Heart, Lung, and Blood Institute (0 Trials) |
|
| exoASO-C/EBPβ / Codiak (0 Trials) |
|
| exoASO-NLRP3 / Codiak (0 Trials) |
|
| exoASO-NRAS / Codiak (0 Trials) |
|
| exoASO-STAT3 / Jazz, Codiak (0 Trials) |
|
| exoASO-STAT6 / Codiak (0 Trials) |
|
| ExoFlo (bone marrow-derived extracellular vesicle and exosomes) / Direct Biologics (0 Trials) |
|
| exoIL-12 / Codiak (0 Trials) |
|
| Exon 43 / Sarepta Therap (0 Trials) |
|
| Exonal (naloxone buccal gel) / Mucodel (0 Trials) |
|
| Exondys 51 (eteplirsen) / Sarepta Therap (3 Trials) |
|
| Exone-R (amlodipine/rosuvastatin/valsartan) / Korea Kolmar (0 Trials) |
|
| ExoPr0 / ReNeuron (0 Trials) |
|
| exosome based peptide therapeutics / Evox Therap (0 Trials) |
|
| Exosome VLP Display Vaccine / Capricor (0 Trials) |
|
| Exosome-based candidates / Jazz, Codiak (0 Trials) |
|
| exosome-delivered viral vaccine / ReNeuron (0 Trials) |
|
| Exosome-MSC Intravenous injection / Dermama Biotech Lab (0 Trials) |
|
| Exosome-SARS-CoV-2 mRNA Vaccine / Capricor (0 Trials) |
|
| exosomes for COVID-19 / Beijing Darwin Cell Biotech (0 Trials) |
|
| exoSTING / Codiak (0 Trials) |
|
| exoVACC based vaccine / Codiak, Ragon Institute (0 Trials) |
|
| EXP-119 / Novoron Biosci, Expesicor (0 Trials) |
|
| EXP-1202 / Expesicor (0 Trials) |
|
| expanded umbilical cord blood cell therapy / Monash Health (0 Trials) |
|
| Exparel (bupivacaine liposome injectable suspension) / Pacira (78 Trials) |
|
| ExPEC-4V / J&J, GSK (0 Trials) |
|
| ExpressGraft (anti-tumor IL-12) / Mallinckrodt (0 Trials) |
|
| EXS21546 / Exscientia, Evotec (0 Trials) |
|
| Exservan (riluzole oral soluble film) / Aquestive, Zambon, Mitsubishi Tanabe (0 Trials) |
|
| EXT608 / Extend Biosci (0 Trials) |
|
| Extavia (IFN-β-1b) / Novartis (7 Trials) |
|
| extended release morphine combined with an atypical stimulant (MGX001) / Shionogi (0 Trials) |
|
| extended-release morphine (EG-P066) / Assertio (0 Trials) |
|
| Extimia (empegfilgrastim biosimilar) / Biocad (2 Trials) |
|
| extracellular matrix hydrogel (ECMH) / Generex (0 Trials) |
|
| Exubera (recombinant human insulin inhalational) / Nektar Therap (1 Trials) |
|
| Exviera (dasabuvir) / AbbVie (6 Trials) |
|
| Exxua (gepirone ER) / Fabre-Kramer (0 Trials) |
|
| Eyevinal (ibudilast) / MediciNova (11 Trials) |
|
| Eylea (aflibercept intravitreal) / Bayer, Regeneron (114 Trials) |
|
| Eylea HD (high-dose aflibercept) / Regeneron, Bayer (0 Trials) |
|
| EYS611 / Eyevensys (0 Trials) |
|
| EYS809 / Eyevensys (0 Trials) |
|
| Eysuvis (loteprednol etabonate nano-suspension 0.25%) / Kala Pharma (0 Trials) |
|
| ezabenlimab (BI 754091) / Boehringer Ingelheim (16 Trials) |
|
| ezaladcigene resoparvovec (VY-AADC) / Voyager (1 Trials) |
|
| ezeprogind (AZP2006) / AlzProtect (0 Trials) |
|
| ezetimibe / Generic mfg. (61 Trials) |
|
| ezetimibe/pitavastatin (1PC111) / Orient Europharma (0 Trials) |
|
| ezetimibe/rosuvastatin (CKD-906) / Chong Kun Dang (0 Trials) |
|
| ezetimibe/rosuvastatin (DP-R207) / Alvogen (0 Trials) |
|
| ezetimibe/rosuvastatin (NVP-1205) / NVP Healthcare (0 Trials) |
|
| ezetimibe/simvastatin / Generic mfg. (5 Trials) |
|
| EZH2 inhibitor / Inventiva (0 Trials) |
|
| EZH2 inhibitor / Domainex (0 Trials) |
|
| EZH2-EED inhibitor / OncoFusion (0 Trials) |
|
| Ezharmia (valemetostat) / Daiichi Sankyo (2 Trials) |
|
| EZM2302 / GSK, Ipsen (0 Trials) |
|
| EZM8266 / Ipsen (0 Trials) |
|
| EZN 4150 / Enzon (0 Trials) |
|
| EZN-2968 / Enzon (1 Trials) |
|
| EZN-3920 / Enzon (0 Trials) |
|
| ezogabine (XEN496) / Xenon (1 Trials) |
|
| ezurpimtrostat (GNS561) / Genoscience Pharma, Genfit (0 Trials) |
|
| ezutromid (SMT C1100) / Sarepta Therap (2 Trials) |
|
|